The DOI matches its Crossref record; 320 of the 320 references it cites were found in a registry or an index.
Melatonin: From Basic Research to Cancer Treatment Clinics
Abstract
Melatonin, the chief secretory product of the pineal gland, is a direct free radical scavenger, an indirect antioxidant, as well as an important immunomodulatory agent. In both in vitro and in vivo investigations, melatonin protected healthy cells from radiation-induced and chemotherapeutic drug–induced toxicity. Furthermore, several clinical studies have demonstrated the potential of melatonin, either alone or in combination with traditional therapy, to yield a favorable efficacy to toxicity ratio in the treatment of human cancers. This study reviews the literature from laboratory investigations that document the antioxidant and oncostatic actions of melatonin and summarizes the evidence regarding the potential use of melatonin in cancer treatment. This study also provides rationale for the design of larger translational research–based clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma 2
Soule, H. D., Vazquez, J., Long, A., Albert, S., & Brennan, M. (1973) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/51.5.1409 · Cited by 2,449
Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*
REITER, R. J. (1991) · Endocrine Reviews · doi:10.1210/edrv-12-2-151 · Cited by 2,192
Self-citationISOLATION OF MELATONIN, THE PINEAL GLAND FACTOR THAT LIGHTENS MELANOCYTES1
Lerner, A. B., Case, J. D., Takahashi, Y., Lee, T. H., & Mori, W. (1958) · Journal of the American Chemical Society · doi:10.1021/ja01543a060 · Cited by 1,758
Melatonin : a potent, endogenous hydroxyl radical scavenger
Tan, D. (1993) · Endocrine Journal · Cited by 1,659
The chemistry of peroxynitrite: A product from the reaction of nitric oxide with superoxide
Pryor, W. A., & Squadrito, G. L. (1995) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1995.268.5.l699 · Cited by 1,511
The Pineal and Its Hormones in the Control of Reproduction in Mammals*
REITER, R. J. (1980) · Endocrine Reviews · doi:10.1210/edrv-1-2-109 · Cited by 1,250
Self-citationActions of melatonin in the reduction of oxidative stress: A review
Reiter, R. J., Tan, D.-X., Osuna, C., & Gitto, E. (2000) · Journal of Biomedical Science · doi:10.1007/bf02253360 · Cited by 1,177
Self-citationDubbels, R., Reiter, R. J., Klenke, E., Goebel, A., Schnakenberg, E., Ehlers, C., Schiwara, H. W., & Schloot, W. (1995) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1995.tb00136.x · Cited by 1,103
Self-citationReppert, S. M., Weaver, D. R., & Ebisawa, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90055-8 · Cited by 1,096
Cited by
Melatonin: Nature’s most versatile biological signal?
Pandi‐Perumal, S. R., Srinivasan, V., Maestroni, G. J. M., Cardinali, D. P., Poeggeler, B., & Hardeland, R. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05322.x · Cited by 875
Night-Shift Work and Risk of Colorectal Cancer in the Nurses' Health Study
Schernhammer, E. S., Laden, F., Speizer, F. E., Willett, W. C., Hunter, D. J., Kawachi, I., Fuchs, C. S., & Colditz, G. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.825 · Cited by 847
Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathways
PANDIPERUMAL, S., TRAKHT, I., SRINIVASAN, V, SPENCE, D., MAESTRONI, G., ZISAPEL, N., & CARDINALI, D. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.001 · Cited by 791
Carlson, L. E., Speca, M., Patel, K. D., & Goodey, E. (2004) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00054-4 · Cited by 740
Melatonin: A Multitasking Molecule
Reiter, R. J., Tan, D.-X., & Fuentes-Broto, L. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(08)81008-4 · Cited by 642
Self-citationNight work and risk of breast cancer
Schernhammer, E. S., Kroenke, C. H., Laden, F., & Hankinson, S. E. (2006) · Epidemiology · doi:10.1097/01.ede.0000190539.03500.c1 · Cited by 484
Night work and breast cancer risk: A systematic review and meta-analysis
Megdal, S. P., Kroenke, C. H., Laden, F., Pukkala, E., & Schernhammer, E. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.05.010 · Cited by 482
“Finally, to date, several clinical trials confirm the potential of melatonin, either alone or in combination with standard therapy regimens, to generate a favorable response in the treatment of human cancers [50].”
BackgroundMelatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Reiter, R., Rosales-Corral, S., Tan, D.-X., Acuna-Castroviejo, D., Qin, L., Yang, S.-F., & Xu, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040843 · Cited by 433
Self-citationMelatonin for the prevention and treatment of cancer
Li, Y., Li, S., Zhou, Y., Meng, X., Zhang, J.-J., Xu, D.-P., & Li, H.-B. (2017) · Oncotarget · doi:10.18632/oncotarget.16379 · Cited by 388
Biological Rhythm and Chronotype: New Perspectives in Health
Montaruli, A., Castelli, L., Mulè, A., Scurati, R., Esposito, F., Galasso, L., & Roveda, E. (2021) · Biomolecules · doi:10.3390/biom11040487 · Cited by 360
Bioactive compounds in wine: Resveratrol, hydroxytyrosol and melatonin: A review
Fernández-Mar, M. I., Mateos, R., García-Parrilla, M. C., Puertas, B., & Cantos-Villar, E. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2011.08.023 · Cited by 347
Night Shift Work and the Risk of Endometrial Cancer
Viswanathan, A. N., Hankinson, S. E., & Schernhammer, E. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2485 · Cited by 338
Melatonin as a radioprotective agent: a review
Vijayalaxmi, Reiter, R. J., Tan, D.-X., Herman, T. S., & Thomas, C. R. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.02.006 · Cited by 303
Self-citationJou, M., Peng, T., Reiter, R. J., Jou, S., Wu, H., & Wen, S. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00140.x · Cited by 265
Self-citationMelatonin as antioxidant, geroprotector and anticarcinogen
Anisimov, V. N., Popovich, I. G., Zabezhinski, M. A., Anisimov, S. V., Vesnushkin, G. M., & Vinogradova, I. A. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.03.012 · Cited by 264
Mills, E., Wu, P., Seely, D., & Guyatt, G. (2005) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00258.x · Cited by 256
Hypotheses for mechanisms linking shiftwork and cancer
Fritschi, L., Glass, D. C., Heyworth, J. S., Aronson, K., Girschik, J., Boyle, T., Grundy, A., & Erren, T. C. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.06.002 · Cited by 201
Melatonin as a biomarker of circadian dysregulation
Mirick, D. K., & Davis, S. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0605 · Cited by 176
Circulating melatonin and the risk of breast and endometrial cancer in women
Viswanathan, A. N., & Schernhammer, E. S. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.002 · Cited by 153
Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses' Health Study Cohort
Schernhammer, E. S., & Hankinson, S. E. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0637 · Cited by 123
Grundy, A., Sanchez, M., Richardson, H., Tranmer, J., Borugian, M., Graham, C. H., & Aronson, K. J. (2009) · Chronobiology International · doi:10.3109/07420520903399987 · Cited by 95
Rotating Night Shift Work and Risk of Ovarian Cancer
Poole, E. M., Schernhammer, E. S., & Tworoger, S. S. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0138 · Cited by 58
Marinac, C. R., Nelson, S. H., Flatt, S. W., Natarajan, L., Pierce, J. P., & Patterson, R. E. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4140-9 · Cited by 55
Metadata
- Authors
- Vijayalaxmi, Thomas, C. R., Reiter, R. J., & Herman, T. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-05-15
- Volume
- 20
- Issue
- 10
- Pages
- 2575-2601
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2105864875
- Cited by
- 361
- References
- 320
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.